Status unknownNCT04639427Co-VISUpdated Jul 14, 2021

Benefits of Using a Transparent Visor to Replace the Face Mask in Speech Therapy Rehabilitation of Oral-Linguo-Facial Praxies in the Context of COVID-19: a Series of Cases

An observational study in Oral-Linguo-Facial Praxies and Covid19, sponsored by Assistance Publique - Hôpitaux de Paris. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-07-14.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

The sponsor has not verified this record recently (last verified Jul 2021), so the status shown — last known as Recruiting — may be out of date.

Study type: Observational
Model: Case-only
Time perspective: Prospective
Enrollment: 4
Ages: 18 Years and older
Sex: All

Study summary

The primary objective of the study is to compare the effectiveness of the use of a transparent covering visor with that of the face mask, with or without the use of video sequences, for speech therapy rehabilitation of oral-linguo-facial praxies in the context of the COVID 19 epidemic.

Read the detailed description

Statistic analysis: single case experimental design (SCED) method.

Conditions studied

Oral-Linguo-Facial Praxies
Covid19

Browse trials for

Keywords

Oral-Linguo-Facial praxies
Covid19
speech therapy rehabilitation

In context

COVID-19

7,641 studies on the registry are indexed under COVID-19; 487 are open to participants now.

This study's planned enrollment of 4 is below the median of 261 across 3,136 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,506 studies on the registry; 1,007 are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 18 Years and older
Sexes eligible: All
Accepts healthy volunteers: No
Sampling method: Non-probability sample

Study population

4 patients hospitalized in the adult neurological Post Intensive Care Rehabilitation Unit (PICRU - SRPR) of Raymond Poincaré hospital.

Inclusion criteria

Aged >= 18 years;
Hospitalization for more than 2 weeks prior to enrollment in the adult post intensive care rehabilitation care unit (PICRU) of Raymond Poincaré hospital in Garches;
With oral-linguo-facial praxis disorders whatever the cause;
Has been informed and not in opposition to participation of the study.

Exclusion criteria

Exclusion Criteria:

Patient with fever or any suspect symptom of a SARS-CoV2 infection;
Planned discharge of hospital in 2 weeks;
Patient with cognitive, phasic or vigilance disorders preventing to understand the study;
Under guardianship or curator;
Patient Under french AME scheme.

Study design

Observational model: Case-only
Time perspective: Prospective
Enrollment: 4 participants (estimated)
Patient registry: No

What researchers measure

Primary outcomes

Oral-Linguo-Facial Motricity Test
Time frame: throughtout of the study, an average of 2 weeks

Study locations

1 of 1 sites recruiting

Unité de Soins de Rééducation Post Réanimation, Service de Médecine Physique et de Réadaptation, Hôpital Raymond Poincaré, APHP
Garches, 92380, France
Recruiting

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Jul 14, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT04639427
Lead sponsor: Assistance Publique - Hôpitaux de Paris
Responsible party: Sponsor
First posted: Nov 20, 2020
Start date: Feb 8, 2021
Primary completion: Jul 2021 (estimated)
Completion: Jul 2021 (estimated)
Last update: Jul 14, 2021

Study contacts

Julie PAQUEREAU, MD

Contact

julie.paquereau@aphp.fr

+ 33 (0)1 47 10 79 00

Julie PAQUEREAU, MD

principal investigator · Unité de Soins de Rééducation Post Réanimation, Service de Médecine Physique et de Réadaptation, Hôpital Raymond Poincaré, APHP

Oversight

Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

COVID-19→

Other studies from this sponsor

Assistance Publique - Hôpitaux de Paris

Start the discussion